BusinessNobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic DisorderBy Nasdaq OMXJun 14, 2017, 5:35 PM UTC
BusinessNobilis Therapeutics Receives a Notice of Allowance for a Patent Covering Treatment of Psychiatric Disorders With Noble GasesBy Nasdaq OMXJun 12, 2017, 10:58 PM UTC
